203 related articles for article (PubMed ID: 22231867)
1. Does fingolimod in multiple sclerosis patients cause macular edema?
Turaka K; Bryan JS
J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
[TBL] [Abstract][Full Text] [Related]
2. Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Minuk A; Belliveau MJ; Almeida DR; Dorrepaal SJ; Gale JS
JAMA Ophthalmol; 2013 Jun; 131(6):802-4. PubMed ID: 23599188
[No Abstract] [Full Text] [Related]
3. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
[TBL] [Abstract][Full Text] [Related]
4. Management of fingolimod-associated macular edema.
Chui J; Herkes GK; Chang A
JAMA Ophthalmol; 2013 May; 131(5):694-6. PubMed ID: 23538612
[No Abstract] [Full Text] [Related]
5. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
Saab G; Almony A; Blinder KJ; Schuessler R; Brennan DC
Arch Ophthalmol; 2008 Jan; 126(1):140-1. PubMed ID: 18195237
[No Abstract] [Full Text] [Related]
6. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
[No Abstract] [Full Text] [Related]
7. Fingolimod-associated macular edema: incidence, detection, and management.
Jain N; Bhatti MT
Neurology; 2012 Feb; 78(9):672-80. PubMed ID: 22371414
[TBL] [Abstract][Full Text] [Related]
8. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R
Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
Fruschelli M; Capozzoli M; Gelmi MC; Masi G; Annunziata P
Int Ophthalmol; 2019 Apr; 39(4):777-781. PubMed ID: 29500696
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
La Mantia L; Prone V; Marazzi MR; Erminio C; Protti A
Neurol Sci; 2014 Sep; 35(9):1485-6. PubMed ID: 24756193
[No Abstract] [Full Text] [Related]
11. Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.
Winges KM; Werner JS; Harvey DJ; Cello KE; Durbin MK; Balcer LJ; Calabresi PA; Keltner JL
J Neuroophthalmol; 2013 Dec; 33(4):322-9. PubMed ID: 24051419
[TBL] [Abstract][Full Text] [Related]
12. Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
Akiyama H; Suzuki Y; Hara D; Shinohara K; Ogura H; Akamatsu M; Hasegawa Y
Medicine (Baltimore); 2016 Jul; 95(29):e4180. PubMed ID: 27442641
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L; Radue EW; O'Connor P; Polman C; Hohlfeld R; Calabresi P; Selmaj K; Agoropoulou C; Leyk M; Zhang-Auberson L; Burtin P;
N Engl J Med; 2010 Feb; 362(5):387-401. PubMed ID: 20089952
[TBL] [Abstract][Full Text] [Related]
14. Early tolerability and safety of fingolimod in clinical practice.
Ontaneda D; Hara-Cleaver C; Rudick RA; Cohen JA; Bermel RA
J Neurol Sci; 2012 Dec; 323(1-2):167-72. PubMed ID: 23040960
[TBL] [Abstract][Full Text] [Related]
15. Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Piscolla E; Hakiki B; Pastò L; Razzolini L; Portaccio E; Amato MP
J Neurol; 2013 Jun; 260(6):1675-7. PubMed ID: 23645219
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Calabresi PA; Radue EW; Goodin D; Jeffery D; Rammohan KW; Reder AT; Vollmer T; Agius MA; Kappos L; Stites T; Li B; Cappiello L; von Rosenstiel P; Lublin FD
Lancet Neurol; 2014 Jun; 13(6):545-56. PubMed ID: 24685276
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
Voon V; Saiva L; O'Kelly S; Keane D
Eur J Clin Pharmacol; 2014 Mar; 70(3):373-5. PubMed ID: 24309839
[No Abstract] [Full Text] [Related]
18. Famous.
Kim MJ; Bhatti MT; Costello F
Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.
Pfender N; Jelcic I; Linnebank M; Schwarz U; Martin R
Neurology; 2015 Jun; 84(23):2377-8. PubMed ID: 25957334
[No Abstract] [Full Text] [Related]
20. Early and recurrent macular oedema in a patient treated with fingolimod.
Cifuentes-Canorea P; Nieves-Moreno M; Sáenz-Francés F; Santos-Bueso E
Neurologia (Engl Ed); 2019 Apr; 34(3):206-207. PubMed ID: 27776961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
